Akero Therapeutics (AKRO) Q4 2025 Earnings

7NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.16
-1.06
-0.96
-0.86

Details

Expected EPS
-0.954043
Actual EPS
-0.945
Surprise EPS
0.01
Surprise Percent
+0.95%

Description

Akero Therapeutics (AKRO) has reported earnings of -0.945 per share for Q4 2025.

0 Comments

Share your thoughts